Dr. Stephen S. Hecht's lab focuses on understanding how cigarette smoking contributes to different types of cancer, particularly lung cancer and head and neck squamous cell carcinoma (HNSCC). The lab investigates the biochemical and genetic mechanisms behind these cancers, exploring why incidence rates vary among different ethnic and racial groups. Their research combines molecular biology, epidemiology, and innovative mass spectrometry techniques to profile DNA damage caused by tobacco smoke, which helps identify individuals at higher risk for cancer, thus promoting more effective prevention strategies.

Dr. Shangqin Guo's lab focuses on understanding how certain proteins, known as linker histones, can influence the development of blood cells from their precursor cells. The research investigates how manipulating these proteins could lead to better outcomes in diseases like cancer and blood disorders by promoting the production of immune cells. The lab uses a variety of genetic models and inhibitors to explore these mechanisms at a molecular level, aiming to create new therapeutic strategies for treating hematological diseases.

Dr. Diane Krause's lab at Yale University focuses on understanding how specific blood cell types, like platelets and red blood cells, are formed from stem cells in the bone marrow. By studying a transcription factor called RUNX1, which is commonly mutated in leukemia, the lab aims to uncover the molecular mechanisms that dictate whether a cell becomes a platelet or a red blood cell. This research has important implications for developing new treatments for blood-related diseases.

Dr. Teresa V. Bowman's lab at Albert Einstein College of Medicine investigates how genetic mutations affect the blood system, focusing particularly on conditions like myelodysplastic syndromes (MDS). By using zebrafish models, the lab explores the role of specific genes and environmental factors in the development and function of hematopoietic stem and progenitor cells, which are crucial for blood cell production. The research aims to uncover insights that could lead to better understanding and treatment of blood disorders, particularly in older adults.

Dr. Jorge Henao-Mejia's lab at the University of Pennsylvania focuses on understanding how early life exposures, particularly to glucocorticoids (stress hormones), influence the immune system and its response to diseases. They investigate how these exposures can reshape immune cells like monocytes and macrophages, linking them to conditions such as obesity, diabetes, allergies, and cancer. The lab employs advanced methods including genomics and single-cell analysis to uncover the mechanisms by which these changes happen and their implications for health.

Dr. Ulrich Hengst's lab at Columbia University focuses on how neurons respond to stress, particularly through a newly discovered secreted protein that helps protect them during stressful situations. This protein, originating from an important transcription factor, has the potential to improve cell survival and mitochondrial function in receiving neurons. The lab investigates how stress triggers the production of this protective factor, its mechanisms of action, and its broader implications for understanding neuroprotection in the brain.

Dr. Kai Xu's lab at Ohio State University focuses on understanding henipaviruses, which can be deadly and have potential for future pandemics. The research aims to study the surface proteins of these viruses to develop better vaccines and treatments. This work is vital as henipaviruses can transfer between animals and humans, leading to serious outbreaks.

Dr. Mike Henne's lab focuses on understanding how our bodies store and utilize fats, specifically through tiny organelles called lipid droplets. The research primarily explores how different organs like the liver and kidneys balance lipid storage and signaling, which is crucial for maintaining health and preventing diseases such as fatty liver disease and type 2 diabetes. By using genetic tools in fruit flies and mice, the lab investigates the pathways that regulate these processes, aiming to uncover new ways to treat metabolic disorders.

Ryan E Hibbs' lab at UC San Diego focuses on understanding the structure and function of important neurotransmitter receptors that are linked to various diseases. Their research explores how nicotinic acetylcholine receptors and GABAA receptors operate in healthy conditions and how they are affected by autoimmune diseases and drug interactions. By using advanced techniques like cryo-electron microscopy and electrophysiology, the lab aims to uncover the fundamental mechanisms behind these receptors to improve treatments for disorders such as myasthenia gravis and epilepsy.

Dr. Annalisa Scimemi's lab studies how specific brain cells, called pyramidal cells, integrate different types of signals in the hippocampus, which is critical for memory and spatial navigation. The lab investigates how a neurotransmitter called glutamate, which is important for communication between neurons, can affect both excitatory and inhibitory signals onto these pyramidal cells. Understanding these mechanisms may help develop new treatments for conditions like epilepsy and autism spectrum disorder.

The lab led by Dr. Kenneth L Rock studies how the immune system responds to cell injury and death, focusing particularly on histones - molecules released when cells die. By identifying novel receptors that detect these histones, the lab aims to understand their role in triggering inflammation and how this relates to various diseases such as strokes and infections. Their findings could help develop new treatments to prevent or treat related health issues.

Dr. Mirko Paiardini's lab focuses on understanding how the body's immune system, particularly natural killer (NK) cells, can be optimized to fight HIV infections. The research aims to identify new treatments that enhance NK cell activity and the effectiveness of broadly neutralizing antibodies to control HIV without the need for continuous antiretroviral therapy. By studying viral control mechanisms in animal models, the lab seeks to develop innovative strategies that could lead to the eradication of HIV in humans.

Dr. Sebastian Patrick Fuchs runs a research lab at the University of Miami School of Medicine focusing on innovative ways to enhance the immune response to HIV treatment using advanced virus-mediated gene delivery systems. His lab is pioneering strategies to prevent the immune system from rejecting therapeutic antibodies delivered through adeno-associated viruses (AAV). This research aims to develop an effective treatment for HIV that could offer long-term solutions without the need for continuous medication.

Dr. Jeremy Luban's lab at the University of Massachusetts Medical School focuses on understanding how the HUSH complex contributes to HIV-1 latency. The research aims to pinpoint the mechanisms by which the HUSH complex silences HIV-1 proviruses in immune cells, which is a key factor in why current treatments don't lead to a cure. By investigating this complex, the lab hopes to discover new strategies for eradicating the virus from the body, which remains dormant in long-lived memory T cells despite antiretroviral therapy.

Dr. Ivona Vasile Pandrea's lab at the University of Pittsburgh focuses on understanding the impact of antiretroviral therapy (ART) on HIV/SIV infection and its relationship with metabolic disorders. The lab explores how factors like inflammation in adipose tissue and adenosine signaling pathways contribute to disease progression in people living with HIV. Their research aims to develop therapeutic strategies that can improve immune function and reduce comorbidities associated with ART-induced weight gain and inflammation.

Dr. Prasun K Datta's lab focuses on understanding the connections between age, HIV, and neurocognitive disorders in people living with HIV. They study how lactate, a byproduct of metabolism, may influence brain health and cognitive function in these individuals, particularly as they age. The research uses nonhuman primate models and explores potential therapeutic approaches to improve the neurological outcomes for those affected by HIV.

Dr. Huanbin Xu's lab focuses on finding effective early treatment strategies to achieve HIV remission in infants. They conduct research using infant macaque models to explore how timely interventions can lead to sustained viral suppression without the need for antiviral treatment. The lab aims to improve prevention methods for mother-to-child transmission of HIV and advance the understanding of how infant immune systems respond to infections and treatments.

Dr. Jian Zhu's lab at Ohio State University focuses on understanding how HIV persists in the body, particularly in the brain, and how factors like drug use influence this persistence. They explore the role of host genes and epigenetic regulation in keeping HIV dormant and investigate potential therapies by repurposing existing FDA-approved drugs. By studying how drugs like cocaine affect gene expression related to HIV, the lab aims to develop strategies for effective treatments.

Dr. Una T. O'Doherty's lab at Emory University focuses on understanding HIV, particularly why HIV reservoirs behave differently in various patients. The lab studies the role of different types of T cells, especially naive CD4+ T cells, which were previously thought to be less significant in HIV persistence. The team uses advanced techniques like machine learning and sequencing to reveal insights that could lead to new ways of reducing the size of the HIV reservoir and improving treatment strategies.

Dr. Rafick Pierre Sekaly's lab focuses on understanding and overcoming HIV infection. They study the immune system's role in maintaining the virus and explore therapeutic strategies, such as the use of IL-10 inhibitors, to restore immune function aiming for an HIV cure. By combining advanced techniques from different research fields, the lab aims to identify mechanisms that contribute to the HIV reservoir and develop innovative interventions for lasting solutions.